Calcium Dobesilate (Cd) in Pigmented Purpuric Dermatosis (PPD): A Pilot Evaluation

Journal of Dermatology

Volumn 31, Issue 2, 2004, Pages 98-103

  Agrawal, Subhav Kumar ^a,b   Gandhi, Vijay ^a   Bhattacharya, Sambit Nath ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

Calcium dobesilate; Capillaritis; Pentoxifylline; Pigmented purpuric dermatoses; PUVASOL

Indexed keywords

ANTACID AGENT; CYCLOSPORIN; DOBESILATE CALCIUM; GRISEOFULVIN; PENTOXIFYLLINE; TRIOXYSALEN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HUMAN; LICHEN AUREUS; LICHENOID ERUPTION; PIGMENTED PURPURIC DERMATOSIS; PIGMENTED PURPURIC LICHENOID DERMATITIS; PILOT STUDY; PROGRESSIVE PIGMENTED PURPURA; PUVA; SIDE EFFECT; SKIN DISEASE;

EID: 1542306763     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00515.x     Document Type: Article

References (20)

1. Arceo A, Berber A, Trevino C: Clinical evaluation of the efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency of the lower limbs, Angiology, 53: 539-544, 2002.
2. Kaur C, Sarkar R, Kanwar AJ, Attri AK, Dabra AK, Kochhar S: An open trial of calcium dobesilate in patients with venous ulcers and stasis dermatitis, Int J Dermatol, 42: 147-152, 2003.
3. Mentes BB, Gorgul A, Tatlicioglu E, Ayoglu F, Unal S: Efficacy of calcium dobesilate in treating acute attacks of hemorrhoidal disease, Dis Colon Rectum, 44: 1489-1495, 2001.
4. Haas A, Trummer G, Eckhardt M, Schmut O, Uyguner I, Pfeiffer KP: Effect of calcium dobesilate on progression of diabetic retinopathy, Klin Montasbl Augenheilkd, 207: 17-21, 1995.
5. Vojnikovic B: Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma, Ophthalmic Res, 23: 12-20, 1991.
6. Tamas P, Csermely T, Ertl T, Vizer M, Szabo I, Prievara FT: Calcium dobesilate lowers the blood pressure in mild to moderate midtrimester hypertension: A pilot study, Gynecol Obstet Invest, 47: 210-213, 1999.
7. Szlavy L, Repa I, Hachen HJ: The influence of CLS2210 on the course of myocardial infarction: A pilot study in man, Angiology, 42: 639-647, 1991.
8. Szlavy L, Repa I, Lengyel I: Calcium dobesilate (CLS2210) protects the myocardium in early acute myocardial infarction: A preliminary randomized, double-blind, placebo controlled study of its effects on biochemical markers, J Cardiovasc Pharmacol, 15: 89-95, 1990.
9. Szabo ME, Haines D, Garay E, et al: Antioxidant properties of calcium dobesilate in ischemic/ reperfused diabetic rat retina, Eur J Pharmacol, 428: 277-286, 2001.
10. Hannaert P, Brunet J, Farine JC, Garay RP: Antioxidant-angioprotective actions of calcium dobesilate in diabetic rats, Int J Angiol, 8: 2-4, 1999.
11. Dowd PM, Champion RH: Purpura, in Champion RH, Burton JL, Burns DA, Breathnach SM (eds): Textbook of Dermatology, 6th ed, Blackwell Science Ltd, Oxford, 1998, pp 2141-2154.
12. Barnhill RL, Busam KJ: Vascular diseases, in Elder D, Elenitsas R, Jaworsky C, Johnson Jr B (eds): Lever's Histopathology of the Skin, Lippincott-Raven Publishers, New York, 1997, pp 185-208.
13. Baselga E, Drolet BA, Esterly NB: Purpura in infants and children, J Am. Acad Dermatol, 37: 673-705, 1997.
14. Aiba S, Tagami H: Immunohistological studies in Schamberg's disease, Arch Dermatol, 124: 1058-1062, 1988.
15. Ghersetich I, Lotti T, Bacci S, Comacchi C, Campanile G, Romagnoli P: Cell infiltrate in progressive pigmented purpura (Schamberg's disease): Immunophenotype, adhesion receptors, and intercellular relationships, Int J Dermatol, 34: 846-850, 1995.
16. Suschek C, Kolb H, Kolb-Bachofen V: Dobesilate enhances endothelial nitric oxide synthase activity in macro- and microvascular endothelial cells, Br J Pharmacol, 122: 1502-1508, 1997.
17. Upchurch GR Jr, Welch GN, Fabian AJ, Pigazzi A, Keaney JF Jr, Loscalzo J: Stimulation of endothelial nitric oxide production by homocyst (e) ine, Atherosclerosis, 132: 177-185, 1997.
18. Brunet J, Farine J-C, Garay RP, Hannaert P: In vitro antioxidant properties of calcium dobesilate, Fund Clin Pharmacol, 12: 205-212, 1998.
19. Berthet P, Farine J-C, Barras J-P: Calcium dobesilate: Pharmacological profile related to its use in diabetic retinopathy, Int J Clin Pharmacol, 53: 631-636, 1999.
20. Pares-Herbute N, Fliche E, Monnier L: Involvement of nitric oxide in the inhibition of aortic smooth muscle cell proliferation by calcium dobesilate, Int J Angiol, Suppl 8: s5-s10, 1999.